Viewing Study NCT00431795


Ignite Creation Date: 2025-12-24 @ 2:17 PM
Ignite Modification Date: 2025-12-27 @ 8:58 AM
Study NCT ID: NCT00431795
Status: TERMINATED
Last Update Posted: 2013-02-13
First Post: 2007-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast Cancer
Sponsor: Hellenic Oncology Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module